MedTrace Logo

Efficacy and Safety of STBF Photodynamic Therapy for Moderate and Severe Acne Vulgaris

NCT05245045 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-02-17

No results posted yet for this study

Summary

This study is being done to evaluate the efficacy and safety of Shengtaibufen photodynamic therapy (STBF-PDT) for treatment of moderate or severe acne vulgaris.

Conditions

Interventions

PROCEDURE

Shengtaibufen Photodynamic Therapy(STBF-PDT)

Shengtaibufen Photodynamic Therapy(STBF-PDT)

PROCEDURE

Red light

Red light

Sponsors & Collaborators

  • Shanghai Dermatology Hospital

    lead OTHER

Principal Investigators

  • Xiuli Wang, MD · Shanghai Skin Disease Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-10
Primary Completion
2023-02-10
Completion
2023-02-10

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05245045 on ClinicalTrials.gov